10.1002/cctc.201900265
ChemCatChem
FULL PAPER
(162 MHz, C6D6): δ -35.99. Anal. calcd. for C26H23O3P: C, 75.35;
Hz), 120.06, 119.25 (d, J = 8.2 Hz), 117.20 (qd, J = 31.1, 2.0 Hz,
–CF3), 104.29 (d, J = 9.8 Hz), 55.39 (–OCH3), 55.16 (–OCH3). 31
P
H, 5.59. Found: C, 75.41; H, 5.64.
2-(2-(2’,6’-(MeO)2-C6H3)-C6H4)(Ph)P-6-F-C6H3OH
(2b).
NMR (162 MHz, C6D6): δ -38.57. 19F NMR (376 MHz, C6D6): δ -
61.93. Anal. calcd. for C27H22F3O3P: C, 67.22; H, 4.60. Found: C,
67.27; H, 4.52.
Following a procedure similar to that for ligand 2a, using 2-F-
C6H4OTHP instead of C6H5OTHP, ligand 2b was obtained in yield
of 57 wt%. 1H NMR (400 MHz, C6D6): δ 7.44–7.39 (m, 1H), 7.37–
7.32 (m, 1H), 7.28 (m, 2H), 7.10 (t, J = 8.3 Hz, 1H), 7.00 (m, 4H),
6.80 (dd, J = 9.5, 1.4 Hz, 2H), 6.43 (td, J = 8.0, 4.6 Hz, 1H), 6.35-
6.32 (m, 2H), 6.28 (d, J = 8.3 Hz, 1H), 3.23 (s, –OCH3, 3H), 3.06
(s, –OCH3, 3H).1H NMR (400 MHz, DMSO-d6): δ 9.65 (s, –OH,
1H), 7.38–7.28 (m, 4H), 7.24 (t, J = 8.3 Hz, 2H), 7.17–7.01 (m,
4H), 6.91 (ddd, J = 7.7, 3.6, 1.4 Hz, 1H), 6.72 (tdd, J = 8.0, 4.8,
1.0 Hz, 1H), 6.59 (dd, J = 8.3, 4.9 Hz, 2H), 6.33 (dd, J = 7.5, 3.9
Hz, 1H), 3.47 (s, –OCH3, 3H), 3.38 (s, –OCH3, 3H). 13C NMR (101
MHz, C6D6): δ 158.45, 158.15, 152.77, 150.37, 147.45 (dd, J =
20.0, 11.2 Hz), 142.86, 142.51, 135.70 (dd, J = 16.9, 6.9 Hz),
134.64–133.42 (m), 131.83 (d, J = 6.5 Hz), 129.88, 129.63,
129.09, 126.75 (d, J = 12.3 Hz), 120.40 (d, J = 5.7 Hz), 119.74 (d,
J = 8.0 Hz), 117.00 (d, J = 18.1 Hz), 104.35 (d, J = 4.6 Hz), 55.50(–
OCH3), 55.12(–OCH3). 31P NMR (162 MHz, C6D6): δ -33.23 (d, J
= 8.7 Hz). 19F NMR (376 MHz, C6D6): δ -136.77 (d, J = 8.7 Hz).
Anal. calcd. for C26H22FO3P: C, 72.22; H, 5.13. Found: C, 72.03;
H, 5.20.
2-(2-(2’,6’-(MeO)2-C6H3)-C6H4)(Ph)P-6-Ph-C6H3OH
(2f).
Following a procedure similar to that for ligand 2a, using 2-Ph-
C6H4OTHP instead of C6H5OTHP, ligand 2f was obtained in yield
of 53 wt%. 1H NMR (400 MHz, C6D6): δ 7.65–7.59 (m, 2H), 7.54
(dd, J = 8.2, 4.7 Hz, 1H), 7.41–7.31 (m, 3H), 7.29–7.10 (m, 10H),
6.78 (t, J = 7.5 Hz, 2H), 6.30 (dd, J = 10.3, 8.4 Hz, 2H), 3.16 (s, –
OCH3, 3H), 3.09 (s, –OCH3, 3H). 1H NMR (400 MHz, DMSO-d6):
δ 8.28 (s, –OH, 1H), 7.47–7.21 (m, 12H), 7.17 (dt, J = 7.4, 1.3 Hz,
1H), 7.15–7.08 (m, 3H), 6.98 (dd, J = 7.6, 2.6 Hz, 1H), 6.87 (t, J =
7.6 Hz, 1H), 6.65–6.55 (m, 3H), 3.50 (s, –OCH3, 3H), 3.39 (s, –
OCH3, 3H). 13C NMR (101 MHz, C6D6): δ 158.39, 158.19, 156.72,
156.52, 142.66, 142.33, 139.04 (d, J = 3.62), 136.14, 136.06,
136.03, 134.11–133.92(m), 132.44, 131.78 (d, J = 6.5 Hz), 129.98,
129.66 (d, J = 9.5 Hz, 5H), 128.91, 127.15, 123.70, 104.13 (d, J
= 9.0 Hz), 55.30 (–OCH3), 55.09 (–OCH3). 31P NMR (162 MHz,
C6D6): δ -35.52. Anal. calcd. for C32H27O3P: C, 78.35; H, 5.55.
Found: C, 78.25; H, 5.48.
2-(2-(2’,6’-(MeO)2-C6H3)-C6H4)(Ph)P-6-C6F5-C6H3OH (2g).
A
2-(2-(2’,6’-(MeO)2-C6H3)-C6H4)(Ph)P-6-CH3-C6H3OH
(2c).
flask was charged with complex 1a (1.8 g, 3.6 mmol) and 20 mL
of dry THF, cooled to 0 oC and a solution of nBuLi in hexane (2.4
M, 1.5 mL, 1.2 equivalents) was added dropwise. The formed
Following a procedure similar to that for ligand 2a, using 2-CH3-
C6H4OTHP instead of C6H5OTHP, ligand 2c was obtained in yield
1
o
of 45 wt%. H NMR (400 MHz, C6D6): δ 7.51 (ddd, J = 7.7, 4.2,
suspension was cooled to -50 C, followed by slow addition of
1.0 Hz, 1H), 7.37–7.27 (m, 3H), 7.11 (t, J = 8.3 Hz, 1H), 7.07–7.02
(m, 1H), 7.01–6.94 (m, 5H), 6.77 (d, J = 8.7 Hz, 1H), 6.69 (t, J =
7.5 Hz, 1H), 6.31 (dd, J = 26.2, 8.3 Hz, 2H), 3.23 (s, –OCH3, 3H),
3.06 (s, –OCH3, 3H), 2.28 (s, 3H, –CH3). 1H NMR (400 MHz,
DMSO-d6): δ 8.33 (s, –OH, 1H), 7.42–7.18 (m, 6H), 7.07 (dddd, J
= 15.9, 7.2, 4.8, 1.8 Hz, 4H), 6.92 (ddd, J = 7.7, 3.5, 1.4 Hz, 1H),
6.66 (t, J = 7.5 Hz, 1H), 6.58 (dd, J = 8.3, 2.2 Hz, 2H), 6.38 (ddd,
J = 7.8, 4.1, 1.7 Hz, 1H), 3.45 (s, –OCH3, 3H), 3.40 (s, –OCH3,
3H), 2.13 (s, –CH3, 3H).13C NMR (101 MHz, C6D6): δ 158.47,
158.16, 158.14, 157.96, 142.71, 142.37, 136.19, 136.12, 136.00
(d, J = 2.5 Hz), 134.10 (d, J = 1.7 Hz), 134.04, 133.85, 132.48,
132.18 (d, J = 2.1 Hz), 131.70 (d, J = 6.6 Hz), 129.74, 129.57,
128.47, 128.41, 128.00, 124.59 (d, J = 1.5 Hz), 121.97 (d, J = 6.0
Hz), 120.56 (d, J = 1.6 Hz), 119.70 (d, J = 8.0 Hz), 104.25, 104.09,
hexafluorobenzene (3.3 g, 18 mmol, 5 equivalents). After reaction
overnight, volatiles was removed by a rotary evaporator, and the
obtained residue was dissolved in degassed ethyl acetate. Few
drops of hydrochloric acid was added slowly. After stirring for 5 h,
the protected group was completely removed monitoring by TLC.
Resultant mixture was quenched by aqueous NaHCO3, and then
extracted with ethyl acetate. Organic phase was dried in
anhydrous magnesium sulfate, and concentrated by a rotary
evaporator. Pure target compound 2g was obtained by column
chromatography (petroleum ether/ethyl acetate = 15/1) as white
solids (1.5 g, 75 wt%). 1H NMR (400 MHz, C6D6): δ 7.45 (ddd, J =
7.6, 4.2, 1.0 Hz, 1H), 7.35–7.24 (m, 3H), 7.23–7.13 (m, 4H), 7.23–
7.06 (m, 5H), 7.10 (t, J = 8.4 Hz, 1H), 7.06–6.95 (m, 5H), 6.92 (d,
J = 7.9 Hz, 1H), 6.92 (d, J = 7.9 Hz, 1H), 6.73 (t, J = 7.6 Hz, 1H),
6.73 (t, J = 7.6 Hz, 1H), 6.35 (d, J = 8.3 Hz, 1H), 6.27 (d, J = 8.3
Hz, 1H), 3.19 (s,–OCH3, 3H), 3.06 (s, –OCH3, 3H). 1H NMR (400
MHz, DMSO-d6): δ 8.98 (s, –OH, 1H), 7.42–7.18 (m, 7H), 7.10 (m,
3H), 6.97 (dd, J = 8.0, 3.4 Hz, 1H), 6.92 (t, J = 7.6 Hz, 1H), 6.72–
6.64 (m, 1H), 6.60 (d, J = 8.4 Hz, 2H), 3.45 (s, –OCH3, 3H), 3.38
(s, –OCH3, 3H).13C NMR (101 MHz, C6D6): δ 158.37, 158.02,
157.37, 157.16, 146.06, 142.78, 142.45, 136.12, 135.09, 135.02,
134.05, 133.87, 133.04, 131.87 (d, J = 6.6 Hz), 130.14, 129.77,
128.72, 128.65, 124.47 (d, J = 9.3 Hz), 120.74, 119.45 (d, J = 8.1
Hz), 113.71, 104.31 (d, J = 11.3 Hz), 55.39 (–OCH3), 55.15 (–
OCH3). 31P NMR (162 MHz, C6D6): δ -36.13. 19F NMR (376 MHz,
C6D6): δ -140.36 (ddd, J = 100.8, 23.8, 8.0 Hz), -156.46 (t, J =
21.5 Hz), -163.35 – -163.72 (m). Anal. calcd. for C32H22F5O3P: C,
55.34 (–OCH3), 55.10 (–OCH3), 16.54 (d, J = 2.7 Hz, –CH3). 31
P
NMR (162 MHz, C6D6): δ -36.61. Anal. calcd. for C27H25O3P: C,
75.69; H, 5.88. Found: C, 75.55; H, 5.84.
2-(2-(2’,6’-(MeO)2-C6H3)-C6H4)(Ph)P-6-CF3-C6H3OH
(2d).
Following a procedure similar to that for ligand 2a, using 2-CF3-
C6H4OTHP instead of C6H5OTHP, ligand 2d was obtained in yield
of 42 wt%. 1H NMR (400 MHz, C6D6): δ 7.40–7.27 (m, 3H), 7.25
(d, J = 7.9 Hz, 1H), 7.22–7.11 (m, 3H), 7.09 (t, J = 8.4 Hz, 1H),
7.00–6.93 (m, 4H), 6.45 (t, J = 7.7 Hz, 1H), 6.28 (dd, J = 18.3, 8.3
Hz, 2H), 3.15 (s, –OCH3, 3H), 3.06 (s, –OCH3, 3H). 1H NMR (400
MHz, DMSO-d6): δ 9.24 (s, –OH, 1H), 7.52 (dd, J = 7.9, 1.7 Hz,
1H), 7.45–7.21 (m, 6H), 7.10 (dddd, J = 23.8, 7.2, 4.6, 2.4 Hz, 3H),
7.03–6.89 (m, 3H), 6.64 (d, J = 8.4 Hz, 1H), 6.55 (d, J = 8.4 Hz,
1H), 3.56 (s, –OCH3,3H), 3.28 (s, –OCH3,3H).13C NMR (101 MHz, 66.21; H, 3.82. Found: C, 66.11; H, 3.74.
C6D6): δ 158.27 (d, J = 0.8 Hz), 157.94 (d, J = 1.1 Hz), 157.78 (d,
J = 1.6 Hz), 157.56 (d, J = 1.6 Hz), 142.76, 142.42, 138.16, 134.85
(d, J = 1.1 Hz), 134.77, 134.70, 133.87, 133.72 (d, J = 1.7 Hz),
133.69, 131.89 (d, J = 6.8 Hz), 130.17, 129.88, 128.71, 128.64,
128.42, 126.04 (d, J = 2.7 Hz), 125.49, 125.39, 123.33 (d, J = 2.7
2-(2-(2’,6’-F2-C6H3)-C6H4)(Ph)P-6-tBu-C6H3OH
(2h).
The
synthetic procedure was similar to that for ligand 2a, except using
2-tBu-C6H4OTHP instead of C6H5OTHP. Note that the reaction of
2-bromo-2’,6’-difluorobiphenyl (2.7 g, 10 mmol) with nBuli was
carried out at -78 °C. 2h was obtained as withe solids in yield of
This article is protected by copyright. All rights reserved.